Pre-Open Movers 3/6: (MWW) (SHFL) (OVTI) Higher; (ONTY) (AEZS) (NTRI) Lower (more...)
Get Alerts MWW Hot Sheet
Join SI Premium – FREE
Below are stocks making major moves in pre-open trading Tuesday:
HIGHER:
Monster Worldwide, Inc. (NYSE: MWW) 7% HIGHER; confirms it will pursue strategic alternatives and hired advisors
Shuffle Master, Inc. (NASDAQ: SHFL) 4% HIGHER; better-than-expected Q4
OmniVision Technologies, Inc. (NASDAQ: OVTI) 3% HIGHER; upgraded
LOWER:
Oncothyreon Inc. (NASDAQ: ONTY) 40% LOWER; disappointing interim analysis of cancer drug Stimuvax from partner Merck KGaA
AEterna Zentaris (NASDAQ: AEZS) 12% LOWER; credibility of positive article questioned.
NutriSystem, Inc. (NASDAQ: NTRI) 12% LOWER; misses Q4 EPS views, guides below the Street
Keryx Biopharmaceuticals (NASDAQ: KERX) 10% LOWER; credibility of positive article questioned.
Skullcandy, Inc. (Nasdaq: SKUL) 8% LOWER; CFO to leave
RAIT Financial Trust New Common (NYSE: RAS) 6% LOWER; stock offering
VIVUS, Inc. (Nasdaq: VVUS) 6% LOWER; Editorial Suggests Possible Pre-Approval CV Testing For VIVUS' Qnexa, Others
Plains All American Pipeline, L.P. (NYSE: PAA) 4% LOWER; stock offering
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) 4% LOWER; stock offering
Quality Distribution, Inc. (Nasdaq: QLTY) 3% LOWER; stock offering
Equity One, Inc. (NYSE: EQY) 3% LOWER; stock offering
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) 1% LOWER; Editorial Suggests Possible Pre-Approval CV Testing For VIVUS' Qnexa, Others
HIGHER:
Monster Worldwide, Inc. (NYSE: MWW) 7% HIGHER; confirms it will pursue strategic alternatives and hired advisors
Shuffle Master, Inc. (NASDAQ: SHFL) 4% HIGHER; better-than-expected Q4
OmniVision Technologies, Inc. (NASDAQ: OVTI) 3% HIGHER; upgraded
LOWER:
Oncothyreon Inc. (NASDAQ: ONTY) 40% LOWER; disappointing interim analysis of cancer drug Stimuvax from partner Merck KGaA
AEterna Zentaris (NASDAQ: AEZS) 12% LOWER; credibility of positive article questioned.
NutriSystem, Inc. (NASDAQ: NTRI) 12% LOWER; misses Q4 EPS views, guides below the Street
Keryx Biopharmaceuticals (NASDAQ: KERX) 10% LOWER; credibility of positive article questioned.
Skullcandy, Inc. (Nasdaq: SKUL) 8% LOWER; CFO to leave
RAIT Financial Trust New Common (NYSE: RAS) 6% LOWER; stock offering
VIVUS, Inc. (Nasdaq: VVUS) 6% LOWER; Editorial Suggests Possible Pre-Approval CV Testing For VIVUS' Qnexa, Others
Plains All American Pipeline, L.P. (NYSE: PAA) 4% LOWER; stock offering
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) 4% LOWER; stock offering
Quality Distribution, Inc. (Nasdaq: QLTY) 3% LOWER; stock offering
Equity One, Inc. (NYSE: EQY) 3% LOWER; stock offering
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) 1% LOWER; Editorial Suggests Possible Pre-Approval CV Testing For VIVUS' Qnexa, Others
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WM (WM) Tops Q1 EPS by 25c
- FS Bancorp (FSBW) Tops Q1 EPS by 8c
- Amerant Bancorp Inc. (AMTB) Misses Q1 EPS by 5c
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Robert W Baird, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!